Innovative Leadership

JOS Pharmaceuticals is led by a visionary team. By melding unique strengths and backgrounds, the team leads with the goal of developing pharmaceutical grade drugs that combine nature and medicine to reimagine possibilities for patients and physicians. Fueled by the desire to pioneer new drugs without side effects or risk for addiction, JOS Pharmaceuticals envisions endless potentiality.

Stephen D. Ochs, M.D.

CEO, Company Founder and Chief Scientific Officer

Stephen Ochs is a retired, board certified anesthesiologist with over 40 years of clinical experience. He is a former clinical professor of anesthesiology at the University of Colorado Health Sciences Center in Denver as well as the former Chief of Department at Penrose Hospital in Colorado Springs.

Jessica Louis

COO and Company Co-Founder and VP for New Product Applications

Jessica Louis is a former world class alpine ski racer. She made the U.S. Alpine Ski Team at age 16. She and her husband, Ehlias, reside in Park City, Utah with their two teenage daughters.

Tyler Andrews

CFO and VP of International Strategic Business Development

Tyler Andrews applies his business development and underwriting experience emphasis from arranging international complex financial instruments to future strategic business relationship building for JOS Pharmaceuticals. His focus will be on the processes required for global product expansion.

Stephen D. Ochs, M.D.

CEO, Company Founder and Chief Scientific Officer

Stephen Ochs is a retired, board certified anesthesiologist with over 40 years of clinical experience. He is a former clinical professor of anesthesiology at the University of Colorado Health Sciences Center in Denver as well as the former Chief of Department at Penrose Hospital in Colorado Springs.

Dr. Ochs co-founded Colorado’s first free-standing, ambulatory, dedicated eye surgery center for cataract, retina and ophthalmic cosmetic surgery located in Colorado Springs. The surgery center performed over 26,000 cataract procedures using awake, conscious sedation techniques developed and refined by him.

To that purpose, JOS Pharmaceuticals was founded to develop a non-THC, all-natural, organic hemp CBD formulation for use as a premedication for the anesthesia technique of awake, conscious sedation. The drug product needed to be safe, non-addictive and effective as defined by the FDA new prescriptive drug pathway for approval. In addition, the product needed to be rapidly orally dissolving thereby providing a positive clinical feedback loop for accurate dosing, precision reproducibility and effective clinical management.

Beginning in 2012, he began seeing an increasing number of general anesthetic patients in the hospital exhibiting clinical signs of narcotic addiction complicating their peri-anesthesia and recovery course after major procedures. As a result, Dr. Ochs became convinced that a non-narcotic analgesic/anxiolytic needed to be developed to combat the increasing opioid national crisis of addictions including as a basis for new anesthetic premedication.

Stephen Ochs is a graduate of the University of Colorado—Boulder, the University of Colorado Medical School—Denver, post graduate medical residency training at the University of Michigan—Ann Arbor, the University of Denver College of Law and the University of Denver Daniels School of Business.

Jessica Louis

COO and Company Co-Founder and VP

for New Product Applications

Jessica Louis is a former world class alpine ski racer and was appointed to the U.S. Alpine Ski Team at age 16. She and her husband, Ehlias, reside in Park City, Utah with their two teenage daughters.

Jessica co-founded JOS with the transformative concept of the need for a titratable, non-THC, CBD pharmaceutical product to allow for a rapid feedback to the individual as to an acceptable level of symptom relief. An immediately orally dissolving tablet was the preferred delivery mechanism required for direct, systemic drug absorption enabling an effective, positive clinical feedback loop.

She is a graduate of the University of Colorado—Boulder earning Phi Beta Kappa, Mortar Board and multiple Scholar-Athlete honors as well as a four-time NCAA All-American in alpine ski racing.

She deferred graduate school at the University of Chicago to start a family. Throughout her career, Jessica has maintained focus on combining her competitive, high performance athletic knowledge with focused, disruptive business entrepreneurship.

Her Company responsibility continues to be on new product development, new market entry and physical rehabilitation support through sports education.

Tyler Andrews

CFO and VP of International

Strategic Business Development

Tyler Andrews applies his enterprise development and underwriting experience from arranging complex, international financial instruments to future strategic business relationships for JOS Pharmaceuticals. His focus will be on the organizational and financial processes required for global product expansion.

As an entrepreneur and mathematician, Tyler is passionate about bringing innovative and disruptive change through metric models which create accelerated enterprise value and leveraged growth. He brings a legacy vision of viewing fundamental changes in traditional ROI metrics where financial returns are commensurate with the social impact from the success of the enterprise.

He is experienced in scale-up of business organizations as increased market penetration and industry sustainability will demand. Systems analysis and design are an important component of his skillset together with quantitative modeling of alternative business expansion opportunities particularly as to entry into new markets and spaces.

Tyler graduated from Indiana Wesleyan University with an emphasis in mathematics, physics and statistics. He was a world class athlete in soccer. He was a member of the NCAA Soccer National Men’s Championship Team 2008-2009 with election to the Hall of Fame in 2019.